ArticleScientific reports2025
Exploring the causal relationship between 16 eye diseases and stroke and their subtypes from a genome-wide perspective.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is increasing evidence that eye diseases and stroke frequently co-occur, but the causal relationships remain elusive. Therefore, Mendelian randomization was used to investigate possible causal relationships between eye diseases and stroke (including its subtypes). This study utilized large-scale genome-wide association study pooled genetic data from two major databases: the IEU OpenGWAS project and the FinnGen databases. We then screened for instrumental variables that met the following three conditions: showing strong associations with the exposure factors, being independent of each other and independent of any confounders, and excluding instrumental variables to ensure that the F-value was greater than 10, and used the Inverse Variance Weighted (IVW) method to conduct causal analyses using the weighted median method, MR-Egger method, MR- PRESSO test and leave-one-out sensitivity test to test the robustness, heterogeneity and horizontal pleiotropy of the results. In order to control for the false positive rate in multiple hypothesis testing, a False Discovery Rate (FDR) correction was also performed. A total of 16 eye diseases and strokes and their subtypes were investigated in this study. In the IVW model, the MR study showed a total of 20 IVWs with p-values less than 0.05. We excluded 6 results with heterogeneity or pleiotropy by sensitivity analysis, and finally the following reliable results were left: (1) patients with age-related macular degeneration had a 5%, 2%, and 7% lower risk of subarachnoid hemorrhage, ischemic stroke, and small-vessel stroke; (2) patients with keratitis had a 12% higher risk of cardioembolic; (3) patients with optic atrophy had a 3% higher risk of stroke; (4) patients with amblyopia had a 3% higher risk of stroke; and (5) patients with other inflammation of eyelid had a small-vessel had a 20% elevated risk; (6) patients with ptosis of the eye had a 17% elevated risk of cardioembolic; (7) patients with strabismus have a 23% elevated risk of small-vessel; (8) patients with stroke had a refractive error by 17%; (9) patients with intracerebral hemorrhage had a 15% increased risk of uveitis; (10) patients with IS had an 11% increased risk of diabetic retinopathy; (11) patients with large-artery atherosclerosis had a 2% increased risk of glaucoma; (12) patients with cardioembolic had a 24% increased risk of amblyopia. From a genetic standpoint, keratitis, amblyopia, other eyelid inflammations, ptosis and strabismus are associated with increased risks of the risk of stroke or its subtypes. Conversely, age-related macular degeneration is associated with reduced risks of the risk of stroke or its subtypes. Furthermore, stroke or its subtypes increase the risks of refractive error, uveitis, diabetic retinopathy, glaucoma, and amblyopia. Nevertheless, it is imperative that these causal relationships be subjected to further verification through fundamental research and Randomized Controlled Trial (RCT).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.